|
Arena Pharmaceuticals, Inc. |
|
|
6166 Nancy Ridge Drive San Diego, CA 92121 USA phone:(858) 453-7200 fax:(858) 453-7210
|
|
| Symbol |
ARNA |
| Exchange |
NASDAQ |
| Founded |
0 |
| Employees |
|
|
|
| www.arenapharm.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Drug discovery company focused on G-Protein Coupled Receptors. |
 |
| Management |
| Jack Lief, CEO; K.A. Ajit Simh, PhD, Vice President, Quality Systems; Dominic P. Behan, Ph.D, Co-Founder, Director, Senior Vice President and Chief Scientific Officer; Robert E. Hoffman, C.P.A., Vice President, Finance and Chief Financial Officer; Louis J. Scotti,
Vice President, Marketing and Business Development; William R. Shanahan, Jr., M.D, J.D, Vice President, Chief Medical Officer; Steven W. Spector, Senior Vice President, General Counsel and Secretary |
| |
|
|
|
|
|
|
|
| Keywords |
| melenoma, protein receptors, human genome |
|
|
|
| Description |
|
Arena Pharmaceuticals, Inc. is a drug discovery and development company focused on GPCRs - G-Protein Coupled Receptors. This single class of receptors is responsible for 80% of cellular communication and accounts for the vast majority of all receptors present in the human body. |
 |
| Technology / Differentiation |
| Many of the leading pharmaceuticals act via GPCRs. Using its proprietary CART and Melanophore technologies together with its GPCR microarrays, Arena's scientists are able to prioritize targets and discover drugs not only at receptors here the endogenous ligand is known, but more importantly, at the so-called orphan receptors found via the Human Genome project where the ligand is not yet known. |
 |
 |
| Strategy |
Arena focuses its efforts in four major therapeutic areas: metabolic disease, cardiovascular diseases, central nervous system disorders and inflammatory diseases. Arean expects to enter the clinic in early 2004 with one of its own internally developed compounds.
|
 |
|
|
|
|
|
|